MX2007002939A - Un procedimiento para fabricar compuestos enantiomeros del imidazol. - Google Patents

Un procedimiento para fabricar compuestos enantiomeros del imidazol.

Info

Publication number
MX2007002939A
MX2007002939A MX2007002939A MX2007002939A MX2007002939A MX 2007002939 A MX2007002939 A MX 2007002939A MX 2007002939 A MX2007002939 A MX 2007002939A MX 2007002939 A MX2007002939 A MX 2007002939A MX 2007002939 A MX2007002939 A MX 2007002939A
Authority
MX
Mexico
Prior art keywords
group
process according
sertaconazole
mononitrate
chosen
Prior art date
Application number
MX2007002939A
Other languages
English (en)
Spanish (es)
Inventor
Ines Petschen
Xavier Camps
Juan Sallares
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35614444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007002939(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of MX2007002939A publication Critical patent/MX2007002939A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MX2007002939A 2004-09-13 2005-09-13 Un procedimiento para fabricar compuestos enantiomeros del imidazol. MX2007002939A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200402184A ES2249992B1 (es) 2004-09-13 2004-09-13 Un procedimiento para fabricar compuestos enantiomericos del imidazol.
PCT/EP2005/009824 WO2006029811A1 (en) 2004-09-13 2005-09-13 Method for manufacturing enantiomeric imidazole compounds

Publications (1)

Publication Number Publication Date
MX2007002939A true MX2007002939A (es) 2007-04-27

Family

ID=35614444

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007002939A MX2007002939A (es) 2004-09-13 2005-09-13 Un procedimiento para fabricar compuestos enantiomeros del imidazol.

Country Status (23)

Country Link
US (1) US7626038B2 (cg-RX-API-DMAC7.html)
EP (1) EP1794152B1 (cg-RX-API-DMAC7.html)
JP (1) JP5048500B2 (cg-RX-API-DMAC7.html)
KR (1) KR100903922B1 (cg-RX-API-DMAC7.html)
CN (1) CN101023077B (cg-RX-API-DMAC7.html)
AR (1) AR050931A1 (cg-RX-API-DMAC7.html)
AT (1) ATE402171T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005284330B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515259A (cg-RX-API-DMAC7.html)
CA (1) CA2577247C (cg-RX-API-DMAC7.html)
DE (1) DE602005008454D1 (cg-RX-API-DMAC7.html)
DK (1) DK1794152T3 (cg-RX-API-DMAC7.html)
ES (1) ES2249992B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007002939A (cg-RX-API-DMAC7.html)
NO (1) NO20071817L (cg-RX-API-DMAC7.html)
PA (1) PA8645501A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060720A1 (cg-RX-API-DMAC7.html)
PL (1) PL1794152T3 (cg-RX-API-DMAC7.html)
PT (1) PT1794152E (cg-RX-API-DMAC7.html)
RU (1) RU2413728C2 (cg-RX-API-DMAC7.html)
TW (1) TWI405760B (cg-RX-API-DMAC7.html)
UY (1) UY29115A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006029811A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8635593B2 (en) * 2008-05-13 2014-01-21 Hewlett-Packard Development Company, L.P. Dynamic autocompletion tool
CN112595803A (zh) * 2020-12-31 2021-04-02 海南海神同洲制药有限公司 一种硝酸舍他康唑乳膏的鉴别方法
CN113501814A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑的纯化方法
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113501815A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑晶型的制备方法
CN113816947A (zh) * 2021-08-25 2021-12-21 海南海神同洲制药有限公司 一种硝酸舍他康唑的重结晶方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1096361B (it) 1978-05-18 1985-08-26 Recordati Chem Pharm Dibenzileteri sostituiti terapeuticamente attivi
JPS57169466A (en) 1981-04-14 1982-10-19 Ota Seiyaku Kk Preparation of imidazole derivative
ES8504779A1 (es) * 1984-02-02 1985-05-01 Ferrer Int Procedimiento de obtencion de nuevos derivados de 1h-imidazol
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
CA1250586A (en) 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
JP3250809B2 (ja) * 1995-01-04 2002-01-28 フエルレル インターナショナル,ソシエダッド アノニマ 1−[2,4−ジクロロ−β−[(7−クロロベンゾ[b]チエニ−3−イル)メトキシ]フェネチル]イミダゾール・1硝酸塩の同質異像B及びC
CZ20012338A3 (cs) * 1998-12-24 2001-12-12 Fujisawa Pharmaceutical Co., Ltd. Imidazolové sloučeniny
CN1191250C (zh) * 2001-09-26 2005-03-02 河北省药物研究所 一种硝酸舍他康唑的合成方法
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.

Also Published As

Publication number Publication date
TW200621756A (en) 2006-07-01
PL1794152T3 (pl) 2008-12-31
US20080108682A1 (en) 2008-05-08
KR20070042206A (ko) 2007-04-20
RU2007113921A (ru) 2008-10-20
UY29115A1 (es) 2005-11-30
JP5048500B2 (ja) 2012-10-17
TWI405760B (zh) 2013-08-21
KR100903922B1 (ko) 2009-06-19
PT1794152E (pt) 2008-10-24
ATE402171T1 (de) 2008-08-15
AR050931A1 (es) 2006-12-06
ES2249992B1 (es) 2007-03-01
US7626038B2 (en) 2009-12-01
WO2006029811A1 (en) 2006-03-23
DK1794152T3 (da) 2008-11-17
RU2413728C2 (ru) 2011-03-10
EP1794152A1 (en) 2007-06-13
CA2577247A1 (en) 2006-03-23
NO20071817L (no) 2007-05-16
EP1794152B1 (en) 2008-07-23
PA8645501A1 (es) 2006-05-16
BRPI0515259A (pt) 2008-07-15
HK1105416A1 (en) 2008-02-15
JP2008512421A (ja) 2008-04-24
CA2577247C (en) 2011-07-05
DE602005008454D1 (de) 2008-09-04
CN101023077A (zh) 2007-08-22
PE20060720A1 (es) 2006-07-11
AU2005284330A1 (en) 2006-03-23
CN101023077B (zh) 2012-05-23
AU2005284330B2 (en) 2011-01-06
ES2249992A1 (es) 2006-04-01

Similar Documents

Publication Publication Date Title
KR102800868B1 (ko) 치환된 1-하이드록시-2-피리돈 화합물의 신규한 제조 방법
AU2005284330B2 (en) Method for manufacturing enantiomeric imidazole compounds
EP1474422B1 (en) R-(-)-1-¬2-(7-CHLOROBENZO-¬B -THIOPHEN-3-Yl-METHOXY)-2-(2,4-DICHLOROPHENYL)ETHYL -1H-IMIDAZOLE
EP0298921B1 (de) 1,2-Benzisoxazole und 1,2-Benzisothiazole
JPS63166869A (ja) 三環式1h−イミダゾール−5−カルボン酸誘導体類
CS261875B2 (en) Herbicide and process for preparing active compounds
HK1105416B (en) Method for manufacturing enantiomeric imidazole compounds
JPH02108686A (ja) 置換ジオキソラニルエチルアミン、その製造法、有害生物防除剤及び新規中間体生成物
JP2798094B2 (ja) 抗菌剤としてのジクロロ置換イミダゾール誘導体
HK1070883B (en) R-(-)-1-2-(7-chlorobenzo-b -thiophen-3-yl-methoxy)-2-(2,4-dichlorophenyl)ethyl -1h-imidazole
KR19980063975A (ko) 광학 활성 (r)-(e)-(4-치환된-페닐-1,3-디티올란-2-일리덴)-1-이미다졸릴아세토니트릴 유도체, 이를 포함하는항진균 조성물 및 이의 제조방법
JPS62155266A (ja) 3,3−ジメチル−1−(4−メトキシイミノメチルフエノキシ)−1−(1,2,4−トリアゾ−ル−1−イル)−ブタン−2−オ−ル類のジアステレオマ−
JPH07508737A (ja) 殺菌・殺カビ作用を有するトリアゾリルブタン誘導体

Legal Events

Date Code Title Description
FG Grant or registration